| __timestamp | MiMedx Group, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 105558000 | 2614539000 |
| Thursday, January 1, 2015 | 167094000 | 3711019000 |
| Friday, January 1, 2016 | 212608000 | 4560733000 |
| Sunday, January 1, 2017 | 285920000 | 5475166000 |
| Monday, January 1, 2018 | 322725000 | 6276700000 |
| Tuesday, January 1, 2019 | 256174000 | 7081200000 |
| Wednesday, January 1, 2020 | 208904000 | 7377200000 |
| Friday, January 1, 2021 | 215332000 | 13634200000 |
| Saturday, January 1, 2022 | 219525000 | 10612500000 |
| Sunday, January 1, 2023 | 266843000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
In pursuit of knowledge
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed MiMedx Group, Inc. in terms of gross profit. From 2014 to 2023, Regeneron's gross profit surged by approximately 332%, peaking at over $11 billion in 2023. In contrast, MiMedx's growth was more modest, with a 153% increase, reaching around $267 million in the same year.
This stark contrast highlights Regeneron's robust market position and innovative prowess, while MiMedx continues to navigate its niche market. The data underscores the importance of strategic investments and innovation in driving financial success in the biotech sector. As the industry evolves, these companies' financial trajectories offer valuable insights into their future potential.
Who Generates Higher Gross Profit? Sanofi or MiMedx Group, Inc.
Gross Profit Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Ascendis Pharma A/S
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Walgreens Boots Alliance, Inc.
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Who Generates Higher Gross Profit? Genmab A/S or MiMedx Group, Inc.
Who Generates Higher Gross Profit? Viatris Inc. or MiMedx Group, Inc.
BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Travere Therapeutics, Inc. vs MiMedx Group, Inc.